About Aurelia
Your health comes first
A safer way forward in aesthetic and metabolic care.
Why we built Aurelia
Powerful treatments deserve serious safeguards.
People are increasingly left to self-dose or experiment with injectables, peptides, and metabolic treatments without consistent clinical oversight. Products obtained through unlicensed or unverified channels may be counterfeit, contaminated, improperly stored, or inconsistently dosed. These are serious health risks—not harmless shortcuts.
We believe aesthetic care should never come at the expense of health. It should begin with a comprehensive baseline, properly sourced products, clinician approval, clear follow-up, and measurements that show how your body is responding.
We treat the science rigorously: verifying sources, evaluating evidence, measuring results, and changing course when the data says we should. Our concierge team stays involved at every stage so you are supported throughout the process.
The FDA and CDC have documented hospitalizations and serious reactions involving counterfeit or mishandled botulinum toxin, and the FDA warns that unapproved GLP-1 products do not undergo its review for safety, effectiveness, or quality. FDA: counterfeit Botox · CDC investigation · FDA: unapproved GLP-1 drugs
The team behind Aurelia
Scientific credentials. Clinical rigor.
Our team brings together scientists published in Nature, clinicians with surgical training at Harvard, and engineers building the measurement and tracking systems behind Aurelia.
MiLoPYP: Self-Supervised Molecular Pattern Mining and Particle Localization In Situ
nextPYP: A Comprehensive and Scalable Platform for Characterizing Protein Variability In Situ Using Single-Particle Cryo-Electron Tomography
Automated Systematic Evaluation of Cryo-EM Specimens with SmartScope
